Search This Blog

Thursday, October 31, 2019

Ironwood Pharmaceuticals EPS beats by $0.28, beats on revenue

Ironwood Pharmaceuticals (NASDAQ:IRWD): Q3 Non-GAAP EPS of $0.40 beats by $0.28; GAAP EPS of $0.13 beats by $0.03.
Revenue of $131.17M (+99.7% Y/Y) beats by $34.07M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)